Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Acoramidis hydrochloride (Alxn2060 hydrochloride) is an orally active and selective kinetic stabilizer of WT and V122I- TTR (transthyretin) . Acoramidis hydrochloride is used in the study for transthyretin amyloidosis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 247.00 | |
10 mg | In stock | $ 397.00 | |
25 mg | In stock | $ 663.00 | |
50 mg | In stock | $ 945.00 | |
100 mg | In stock | $ 1,280.00 | |
500 mg | In stock | $ 2,570.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 272.00 |
Description | Acoramidis hydrochloride (Alxn2060 hydrochloride) is an orally active and selective kinetic stabilizer of WT and V122I- TTR (transthyretin) . Acoramidis hydrochloride is used in the study for transthyretin amyloidosis. |
In vitro | Acoramidis (AG10, 0.1-10 μM for TTR ~5 μM) stabilizes V122I- and WT-TTR equally well and also exceeds their efficacy to stabilize WT and mutant TTR in whole serum [1] . Acoramidis (AG10) stimulates the mitochondrial QO2 in a concentration-dependent manner between 10 and 100 μM [3] . Acoramidis (AG10) has very minimal inhibition of two common off-targets in drug discovery, the potassium ion channel hERG (IC 50 > 100 μM) and a number of cytochrome P450 isozymes (IC 50 > 50 μM) (low toxicity) [1] . Western Blot Analysis [1] . Cell Line: Human serum (TTR ~5 μM). Concentration: 0.1 and 10 μM. Incubation Time: 72 h. Result: Was significantly more effective than tafamidis in stabilizing TTR. The concentration of AG10 to 10 μM resulted in stabilization of almost all of TTR in serum. |
In vivo | In an animal model using Wistar rats [1], AG10 was administered orally via gavage at a dosage of 50 mg/kg/d for toxicity analysis over a 28-day period. Subsequent results indicated a plasma C max of approximately 40 μM. Histopathological evaluations of the liver, kidney, heart, spleen, thymus, and lung revealed no signs of pathological processes in the AG10-treated subjects. |
Synonyms | AG10 hydrochloride, Alxn2060 hydrochloride |
Molecular Weight | 328.77 |
Formula | C15H18ClFN2O3 |
CAS No. | 2242751-53-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 58.5 mg/mL (177.9 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Acoramidis hydrochloride 2242751-53-5 Others Alxn2060 Hydrochloride AG10 hydrochloride AG-10 Hydrochloride AG10 Hydrochloride Alxn2060 hydrochloride AG 10 Hydrochloride Acoramidis Hydrochloride inhibitor inhibit